64Cu-labeled panitumumab for PET imaging of EGFR plus non-small cell lung cancer: Subcutaneous and metastatic mouse models

被引：0
|
作者：
Wuest, Frank [1 ]
Sarrami, Nasim [1 ]
Wuest, Melinda [1 ]
Paiva, Igor [1 ]
Leier, Samantha [1 ]
Lavasanifar, Afsaneh [1 ]
机构：
[1] Univ Alberta, Edmonton, AB, Canada
来源：
NUCLEAR MEDICINE AND BIOLOGY | 2023年 / 126卷
基金：
加拿大自然科学与工程研究理事会;
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
P-169
引用
收藏
页码：S188 / S188
页数：1
相关论文
共 50 条
  • [21] Quantification of EGFR mutations in primary and metastatic tumors in non-small cell lung cancer
    Bing Wei
    Ke Yang
    Jiuzhou Zhao
    Yuxi Chang
    Zihui Ma
    Bing Dong
    Yongjun Guo
    Jie Ma
    Journal of Experimental & Clinical Cancer Research, 33
  • [22] Small-Animal PET Imaging of Pancreatic Cancer Xenografts Using a 64Cu-Labeled Monoclonal Antibody, MAb159
    Wang, Hui
    Li, Dan
    Liu, Shuanglong
    Liu, Ren
    Yuan, Hong
    Krasnoperov, Valery
    Shan, Hong
    Conti, Peter S.
    Gill, Parkash S.
    Li, Zibo
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (06) : 908 - 913
  • [23] Evaluation of 64Cu-labeled dipicolylamine (DPA) as a small-molecule PET probe for in vivo imaging of phosphatidylserine exposure
    Chen, Kai
    Yap, Li-Peng
    Park, Ryan
    Gray, Brian
    Pak, Koon
    Conti, Peter
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [24] Development of a 64Cu-labeled immuno-PET probe for imaging Sialyl Lewis X in breast cancer
    Kaur, Jatinder
    Wuest, Melinda
    Kawashima, Hiroto
    Wuest, Frank
    NUCLEAR MEDICINE AND BIOLOGY, 2022, 108 : S221 - S221
  • [25] Clinical benefit of EGFR-TKIs plus radiotherapy for treating EGFR-mutated metastatic non-small cell lung cancer.
    Wang, Ran Lin
    Li, Tao
    Lv, Jiahua
    Sun, Chang
    Shi, Qiuling
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [26] Imaging of non-small cell lung cancer
    Munden, RF
    Bruzzi, J
    RADIOLOGIC CLINICS OF NORTH AMERICA, 2005, 43 (03) : 467 - +
  • [27] Assessing EGFR gene mutation status in non-small cell lung cancer with imaging features from PET/CT
    Jiang, Mengmeng
    Zhang, Yiqian
    Xu, Junshen
    Ji, Min
    Guo, Yinglong
    Guo, Yixian
    Xiao, Jie
    Yao, Xiuzhong
    Shi, Hongcheng
    Zeng, Mengsu
    NUCLEAR MEDICINE COMMUNICATIONS, 2019, 40 (08) : 842 - 849
  • [28] Sitravatinib plus tislelizumab in patients with metastatic non-small cell lung cancer (NSCLC)
    Zhou, Q.
    Yu, X.
    Gao, B.
    Ma, Z.
    Chu, Q.
    Huang, D.
    Zhao, J.
    Day, D.
    Body, A. L.
    Pan, H.
    Cui, J.
    Chen, C.
    Xiang, X.
    Fei, C.
    Yang, L.
    Wu, Y-L.
    ANNALS OF ONCOLOGY, 2021, 32 : S996 - S997
  • [29] Sitravatinib plus tislelizumab in patients with metastatic non-small cell lung cancer (NSCLC)
    Zhou, Q.
    Yu, X.
    Gao, B.
    Ma, Z.
    Chu, Q.
    Huang, D.
    Zhao, J.
    Day, D.
    Body, A. L.
    Pan, H.
    Cui, J.
    Li, H.
    Sun, J.
    Zhang, J.
    Fei, C.
    Wu, Y-L.
    ANNALS OF ONCOLOGY, 2022, 33 : S1 - S2
  • [30] Metastatic Non-Small Cell Lung Cancer to the Small Bowel
    Levy, Sara
    Shroff, Sagar
    Qayed, Emad
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S421 - S421
12345